KEGG   DGROUP: Immune checkpoint inhibitorHelp
Entry
DG02938                     DGroup                                 

Name
Immune checkpoint inhibitor
Member
D04603  
Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)  <JP/US>
D06657  
Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN)
D10316  
Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)  <JP/US>
D10574  
Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)  <JP/US>
D11108  
Cemiplimab (USAN)  <US>
D11366  
Dostarlimab (USAN)
D10808  
Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN)  <JP/US>
D10817  
Avelumab (USAN); Avelumab (genetical recombination) (JAN)  <JP/US>
D10773  
Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)  <JP/US>
Class
Antineoplastic
Comment
Antineoplastic
LinkDB All DBs

» Japanese version

DBGET integrated database retrieval system